Evaluating neurofilament light chain serum levels as a diagnostic marker for Lyme neuroborreliosis
Background: Serum neurofilament light chain (sNfL) is a biomarker for neuro-axonal injury. Objectives: To assess sNfL’s utility as a diagnostic marker for Lyme neuroborreliosis (LNB). Methods: We compared serum and CSF NfL levels in LNB patients and age-matched controls. Age-adjusted NfL values were...
Saved in:
Main Authors: | Cédric Hirzel, Annina Grütter, Denis Grandgirard, Robert Hoepner, Franziska Suter-Riniker, Stephen L. Leib |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-01-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/17562864251314011 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lyme neuroborreliosis as initial expression of Lyme disease in an elderly patient
by: Emidio Mata, et al.
Published: (2025-01-01) -
The role of neurofilament light chain in the context of neurological disorders
by: V. Taluntienė, et al.
Published: (2020-12-01) -
Correlation between serum neurofilament light chain and short-term outcomes in patients with hypertensive intracerebral hemorrhage
by: Jun Zhou, et al.
Published: (2025-02-01) -
Prognostic Value of Cerebrospinal Fluid and Serum Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: A Correlation Study
by: Siqi Dong, et al.
Published: (2025-01-01) -
Neurofilament Light Chain Levels in Serum and Cerebrospinal Fluid Do Not Correlate with Survival Times in Patients with Prion Disease
by: Mika Shimamura, et al.
Published: (2024-12-01)